20 LATEST RESOURCES (35 INDEXED)
VA/DoD Clinical Practice Guideline for Management of First-Episode Psychosis and Schizophrenia · January 2023
Publications (Guidelines)
US Department of Veterans Affairs
History of Suicide Attempt and Clozapine Treatment in Veterans with Schizophrenia or Schizoaffective Disorder · November 2022
Articles
Primary Care Companion for CNS Disorders
Repetitive Transcranial Magnetic Stimulation for Psychiatric Symptoms in Long-Term Hospitalized Veterans with Schizophrenia: A Randomized Double-Blind Controlled Trial · September 2022
Articles
Frontiers in Psychiatry
Penetrance and Pleiotropy of Polygenic Risk Scores for Schizophrenia, Bipolar Disorder, and Depression among Adults in the US Veterans Affairs Health Care System · September 2022
Articles
JAMA Psychiatry
Transitioning from Once-Monthly to Once-Every-3-Months Paliperidone Palmitate among Veterans with Schizophrenia · October 2021
Articles
Neuropsychiatric Disease and Treatment
Predictors of High-Intensity Psychiatric Service Utilization by Veterans Health Administration Patients with Early Psychosis · August 2021
Articles
Psychiatric Services
Differences in Antipsychotic Treatment Discontinuation among Veterans with Schizophrenia in the U.S. Department of Veterans Affairs · July 2021
Articles
American Journal of Psychiatry
Risk Factors and Antipsychotic Usage Patterns Associated with Terminal Delirium in a Veteran Long-Term Care Hospice Population · May 2021
Articles
NCBI>Federal Practitioner
Preliminary Efficacy of CBT-I for Psychosis in a Veteran Sample (Meetings-Events) · May 2021
Abstracts
Sleep
Healthcare Resource Utilization and Costs among Patients with Schizophrenia Switching from Oral Risperidone/Paliperidone to Once-Monthly Paliperidone Palmitate: A Veterans Health Administration Claims Analysis · April 2020
Articles
Current Therapeutic Research
Transitioning from Oral Risperidone or Paliperidone to Once-Monthly Paliperidone Palmitate: A Real-World Analysis among Veterans Health Administration Patients with Schizophrenia Who Have Had at Least One Prior Hospitalization · August 2019
Articles
Current Medical Research and Opinion
Health Outcomes among Patients Diagnosed with Schizophrenia in the US Veterans Health Administration Population Who Transitioned from Once-Monthly to Once-Every-3-Month Paliperidone Palmitate: An Observational Retrospective Analysis · August 2019
Abstracts
Advances in Therapy
Antipsychotic Use and Fracture Risk: An Evaluation of Incidence at a Veterans Affairs Medical Center · January 2019
Articles
Mental Health Clinician
Health Care Resource Utilization and Costs Associated with Transitioning to 3-Month Paliperidone Palmitate among US Veterans · August 2018
Articles
Clinical Therapeutics
Outcomes Comparison of Long-Acting Injectable Antipsychotic Initiation in Treatment-Naive Veterans in the Inpatient versus Outpatient Setting · January 2018
Articles
Mental Health Clinician
Impact of Paliperidone Palmitate versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia and Comorbid Substance Abuse · June 2017
Articles
Clinical Therapeutics
Disturbed EEG Sleep, Paranoid Cognition and Somatic Symptoms Identify Veterans with Post-Traumatic Stress Disorder · November 2016
Articles
BJPsych Open
Impact of Paliperidone Palmitate versus Oral Atypical Antipsychotics on Health Care Resource Use and Costs in Veterans with Schizophrenia · October 2016
Abstracts
Journal of Clinical Psychiatry
Feasibility and Challenges of Inpatient Psychotherapy for Psychosis: Lessons Learned from a Veterans Health Administration Pilot Randomized Controlled Trial · July 2016
Articles
BMC Research Notes
Organizational Characteristics of Veterans Affairs Clinics with High and Low Utilization of Clozapine · June 2016
Articles
Psychiatric Services